- Home
- PB vs PCVX Comparison
PB vs PCVX Comparison
Compare PB & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PB
- PCVX
- Stock Information
- Founded
- PB 1983
- PCVX 2013
- Country
- PB United States
- PCVX United States
- Employees
- PB N/A
- PCVX N/A
- Industry
- PB Major Banks
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- PB Finance
- PCVX Health Care
- Exchange
- PB Nasdaq
- PCVX Nasdaq
- Market Cap
- PB 6.3B
- PCVX 6.0B
- IPO Year
- PB 1998
- PCVX 2020
- Fundamental
- Price
- PB $67.86
- PCVX $49.28
- Analyst Decision
- PB Buy
- PCVX Strong Buy
- Analyst Count
- PB 17
- PCVX 7
- Target Price
- PB $80.56
- PCVX $101.67
- AVG Volume (30 Days)
- PB 1.1M
- PCVX 1.5M
- Earning Date
- PB 10-29-2025
- PCVX 11-04-2025
- Dividend Yield
- PB 3.40%
- PCVX N/A
- EPS Growth
- PB 19.26
- PCVX N/A
- EPS
- PB 5.60
- PCVX N/A
- Revenue
- PB $1,239,671,000.00
- PCVX N/A
- Revenue This Year
- PB $9.28
- PCVX N/A
- Revenue Next Year
- PB $19.72
- PCVX N/A
- P/E Ratio
- PB $12.19
- PCVX N/A
- Revenue Growth
- PB 7.88
- PCVX N/A
- 52 Week Low
- PB $61.07
- PCVX $27.66
- 52 Week High
- PB $86.76
- PCVX $94.76
- Technical
- Relative Strength Index (RSI)
- PB 58.72
- PCVX 65.64
- Support Level
- PB $64.18
- PCVX $47.02
- Resistance Level
- PB $68.90
- PCVX $50.18
- Average True Range (ATR)
- PB 1.42
- PCVX 2.20
- MACD
- PB 0.13
- PCVX 0.21
- Stochastic Oscillator
- PB 77.22
- PCVX 90.46
About PB Prosperity Bancshares Inc.
Prosperity Bancshares Inc provides retail and commercial banking services to individuals and small to midsize businesses. It provides a wide array of financial products and services to businesses and consumers throughout Texas and Oklahoma. The group provides Personal, Business, Mortgage, and Banking Services.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.